These renal cysts responded to some drugs known to inhibit cyst formation in ADPKD, such as mammalian target of rapamycin (mTOR), indicating that these models can be used to screen drug compounds that prevent renal cyst formation [31] (Fig. 3e). The gene discussed is MTOR; the disease is cystic kidney disease.